Sapience Therapeutics is a preclinical-stage biotechnology company focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. The company's drug development program involves translating science into no...Show all
Company (Alive / Active)
Phone: 914-607-6931
500 Mamaroneck Ave
Suite 320
Harrison, 10528
New York, United States
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|---|---|---|
Celgene | Corporation | Summit, New Jersey, United States | Series A |
Bristol-Myers Squibb | Corporation | New York, New York, United States | Unattributed |
Eshelman Ventures | Venture Capital | Wilmington, North Carolina, United States | Series A |
Columbia University | Academic/University | New York, New York, United States | Series A |
Healthlink Capital | Other | Series A |
Name | Firm |
---|---|
Login to see details | Edge Therapeutics |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Atf5 peptide variants and uses thereof | Jan 03, 2019 | Jan 07, 2020 | Patent |
Cell-penetrating atf5 polypeptides and uses thereof | Feb 17, 2018 | Jun 11, 2019 | Patent |